EIM
ALDR

Essex Investment Management’s Alder Biopharmaceuticals ALDR Stock Holding History

Essex Investment Management’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-32,406
Closed -$1.06M – 392
2016
Q3 		$1.06M Buy
+32,406
New +$987K 0.17% 152

Other funds holding ALDR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Essex Investment Management's ALDR Position: Q4 2016 in Review

Essex Investment Management sold out of Alder Biopharmaceuticals (ALDR) in Q4 2016, closing a stake of 32,406 shares — an estimated $1.06M sold.

Essex Investment Management first reported a position in ALDR in Q3 2016 and held it in 1 quarter. The position peaked at $1.06M in Q3 2016. 145 funds tracked by Wall St. Rank hold ALDR as of Q4 2016.

  • Essex Investment Management reported no remaining Alder Biopharmaceuticals position as of Q4 2016 after selling out during the quarter.
  • Essex Investment Management sold 32,406 Alder Biopharmaceuticals shares in Q4 2016, an estimated $1.06M.
  • Essex Investment Management first reported a position in Alder Biopharmaceuticals in Q3 2016 and held it in 1 quarter.
  • Essex Investment Management's Alder Biopharmaceuticals position peaked at $1.06M in Q3 2016.
  • 145 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2016.

Based on Essex Investment Management's 13F filing for Q4 2016, filed 8 Feb 2017.